← Back to Search

Contraceptive Education for Birth Control

N/A
Waitlist Available
Led By Cynthia C. Harper, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Students at 28 community colleges must be: female, aged 18-25, English-speaking, sexually active (vaginal sex with a male partner) in the last year, not currently pregnant, not wanting to become pregnant in the next 12 months, at risk of pregnancy (including not sterilized), enrolled in the current term at the participating community college, first-time college students, and willing to be contacted by email and telephone over the next 12 months. Clinic staff must be employed by a participating clinic and offer clinical care, counseling, or education for contraception at the clinic. Colleges eligible to be study sites must be accredited community colleges, not share health center staff with a participating college site, have no active LARC intervention, and enroll students ages 18-25 years.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial will test whether providing training and education to clinic staff and young women on contraceptive methods will lead to increased knowledge and access to these methods, specifically IUDs and implants, among community college students.

Who is the study for?
This study is for sexually active female students aged 18-25 who are first-time college attendees at participating community colleges. They should not be pregnant, must want to avoid pregnancy for the next year, and cannot have been sterilized. Both students and staff at student health centers can participate.Check my eligibility
What is being tested?
The trial aims to see if training clinic staff and educating young women on birth control methods like IUDs and implants increases their knowledge and access to contraception.See study design
What are the potential side effects?
Since this trial focuses on education rather than medical treatment, there are no direct side effects from interventions. However, general awareness of potential side effects related to contraceptive use will likely be discussed during the educational sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in student knowledge of full range of contraceptive methods (questionnaire)
Secondary outcome measures
Change in LARC use over 12 months (questionnaire)
Contraceptive Agents
Long-Acting Reversible Contraception
+1 more
Other outcome measures
Certificate or degree completion
Certificate or degree completion (ordinal outcome including categories for on-time progression for graduation, delayed progression or dropout), measured by student report (questionnaire)
Change in provider LARC practices (questionnaire)
+8 more

Side effects data

From 2011 Phase 3 trial • 407 Patients • NCT01236768
6%
Cervical dysplasia
5%
Nasopharyngitis
4%
Sinusitis
4%
Sinus Congestion
3%
Nausea
2%
Upper respiratory infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
AG200-15
Levora

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Contraceptive Training and EducationExperimental Treatment1 Intervention
Colleges assigned to this arm receive a one-day UCSF Continuing Medical Education (CME # MMC18087) accredited training on contraceptives and technical assistance. The training is for staff at the student health center and local health centers where they refer for contraceptive services. Students attending colleges assigned to this arm receive education about contraceptive methods and how to access services.
Group II: Nutrition EducationPlacebo Group1 Intervention
Students attending colleges assigned to this arm receive nutrition education about the impacts of sugar on health.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,493 Previous Clinical Trials
11,929,712 Total Patients Enrolled
Cynthia C. Harper, PhDPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Contraceptive Training and Education Clinical Trial Eligibility Overview. Trial Name: NCT03519685 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an upper age restriction for eligibility in this trial?

"To match the eligibility criteria of this trial, applicants must be aged between 18 to 25. There are an additional 22 trials for those below 18 and 16 for seniors above 65 years old."

Answered by AI

Is this clinical research currently open to recruitment?

"According to the details posted on clinicaltrials.gov, this trial is actively seeking qualified participants. It was initially published in April 2018 and had its last edit done in June 2021."

Answered by AI

What is the participant capacity for this trial?

"Affirmative. Clinicaltrials.gov data indicates that this experiment is currently recruiting patients; it was initially posted on April 9th 2018 and most recently updated on June 16th 2021. 2,072 participants are sought from a single trial site."

Answered by AI

To whom is the opportunity to take part in this experiment available?

"To qualify for this research, participants must be between 18 and 25 years old and use contraception. In total, 2072 applicants will receive a place in the trial."

Answered by AI
~302 spots leftby Mar 2025